Agomez, Eugenia D.

HRN: 01-88-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
CEFTRIAXONE 1G (VIAL)
05/05/2023
05/11/2023
IV
2g
Od
Uti
Waiting Final Action 
05/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2023
05/13/2023
IVTT
500 Mg
Q8
AGE With Mod DHN; Intestinal Amoebiasis
Waiting Final Action 
05/08/2023
METRONIDAZOLE 500MG (TAB)
05/08/2023
05/16/2023
PO
500 Mg
TID
Infectious Diarrhea Sec To Intestinal Amoebiasis
Waiting Final Action 
08/03/2023
CEFTRIAXONE 1G (VIAL)
08/04/2023
08/10/2023
IV
2gm
Q24H
UTI
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: